Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-643 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
filingDate |
2010-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2012-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20120130752-A |
titleOfInvention |
Compositions and Methods for the Treatment of Angiogenesis-Related Eye Diseases |
abstract |
The present invention generally relates to low-dose fusion proteins comprising low-dose rhostostomine variants, and in particular rhodostomine variants, wherein the rhodostomin variant is a human serum albumin (HSA wherein cysteine residue at position 34 of the HSA amino acid sequence is replaced by serine. A composition and method for the treatment and / or prophylaxis of angiogenesis-related ocular disease using |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107206047-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015147616-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10463720-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107206047-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10632181-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016108669-A1 |
priorityDate |
2009-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |